Cargando…
Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDR
Cancer is one of the leading causes of death worldwide, and the development of resistance to chemotherapy drugs is a major challenge in treating malignancies. In recent years, researchers have focused on understanding the mechanisms of multidrug resistance (MDR) in cancer cells and have identified t...
Autores principales: | Bin Kanner, Yuval, Teng, Qiu-Xu, Ganoth, Assaf, Peer, Dan, Wang, Jing-Quan, Chen, Zhe-Sheng, Tsfadia, Yossi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651738/ https://www.ncbi.nlm.nih.gov/pubmed/38026953 http://dx.doi.org/10.3389/fphar.2023.1290255 |
Ejemplares similares
-
Extracellular mutation induces an allosteric effect across the membrane and hampers the activity of MRP1 (ABCC1)
por: Bin Kanner, Yuval, et al.
Publicado: (2021) -
PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR
por: Anreddy, Nagaraju, et al.
Publicado: (2014) -
Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport
por: Evers, R, et al.
Publicado: (2000) -
Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
por: Lo, Yu-Li, et al.
Publicado: (2014) -
Correction: Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
Publicado: (2014)